Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

931
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
931
Autoimmune Disorders01:29

Autoimmune Disorders

557
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
557
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.3K
Overview
69.3K
T Cell Types and Functions01:24

T Cell Types and Functions

1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Hypersensitivities01:30

Hypersensitivities

830
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
830

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Should autologous HSCT be a first-line option in highly active MS: YES.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosis.

Brain : a journal of neurology·2026
Same author

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.

Bone marrow transplantation·2025
Same author

Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same author

Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT).

British journal of haematology·2025
Same author

Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.

Multiple sclerosis and related disorders·2025

関連する実験動画

Updated: Jul 31, 2025

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

7.2K

自己免疫疾患における耐性を再設定する

Paolo A Muraro1,2

  • 1Department of Brain Sciences, Imperial College London, London, UK.

Science (New York, N.Y.)
|May 4, 2023
PubMed
まとめ

血造性幹細胞移植は成功している治療法ですが,その仕組みは完全に理解されていません. この重要な治療の背後にあるメカニズムを明らかにするには,さらなる研究が必要です.

科学分野:

  • 免疫学
  • 血液学
  • 腫瘍学

背景:

  • 自体造血幹細胞移植 (AHSCT) は広く使用されている治療戦略です.
  • AHSCTは,様々な血液学的悪性腫瘍と自己免疫疾患の治療に有効であることが示されています.
  • AHSCTの有効性の基礎となる正確な生物学的メカニズムは,まだ完全に解明されていません.

研究 の 目的:

  • 本体造血幹細胞移植の作用の根本的なメカニズムを調査する.
  • AHSCTの有効性に関与する重要な細胞および分子経路を特定する.
  • AHSCTの治療効果を全面的に理解する.

主な方法:

  • この研究では,in vitroアッセイとin vivoモデルを組み合わせた.
  • 細胞集団とその活性化状態を分析するために,フローサイトメトリと遺伝子発現プロファイリングを使用した.
  • 重要なタンパク質の相互作用とシグナル伝達経路を特定するために,プロテオミック分析が行われました.

主要な成果:

  • AHSCT後の免疫細胞集団の 顕著な変化を示しています
  • 特定のサイトカインプロファイルとシグナリングカスケードは,治療応答の重要なメディエーターとして特定されました.

さらに関連する動画

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.6K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.4K

関連する実験動画

Last Updated: Jul 31, 2025

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

7.2K
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.6K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.4K
  • AHSCTの成功において,T細胞と関連する分子の役割が示唆されている.
  • 結論:

    • オートログの造血幹細胞移植は,複雑な免疫調節メカニズムを通してその効果を発揮する.
    • これらのメカニズムの理解は AHSCT プロトコルと患者選択の最適化への道を開くことができます.
    • 特定された経路のさらなる調査により,新しい治療目標が明らかになる可能性があります.